US Stock MarketDetailed Quotes

ITOS ITeos Therapeutics

Watchlist
  • 15.730
  • -0.570-3.50%
Close Jul 19 16:00 ET
  • 15.610
  • -0.120-0.76%
Post 18:42 ET
568.21MMarket Cap-4161P/E (TTM)

ITeos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
-95.29%12.6M
0
0
0
-91.74%12.6M
-22.38%267.63M
-77.59%53.91M
-81.31%19.49M
41.72M
Operating revenue
--0
-95.29%12.6M
--0
--0
--0
-91.74%12.6M
-22.38%267.63M
-77.59%53.91M
-81.31%19.49M
--41.72M
Cost of revenue
Gross profit
Operating expense
24.79%45.48M
14.08%157.48M
5.98%37.24M
24.23%42.23M
9.21%41.44M
17.70%36.45M
53.91%138.04M
35.02%35.14M
45.44%33.99M
43.07%37.94M
Selling and administrative expenses
6.51%12.7M
14.67%50.4M
11.42%12.37M
17.49%12.64M
17.12%13.44M
12.36%11.93M
8.50%43.95M
15.66%11.1M
22.82%10.76M
-24.04%11.47M
-General and administrative expense
6.51%12.7M
14.67%50.4M
11.42%12.37M
17.49%12.64M
17.12%13.44M
12.36%11.93M
8.50%43.95M
15.66%11.1M
22.82%10.76M
-24.04%11.47M
Research and development costs
34.89%34.53M
16.37%113.3M
9.27%27.78M
28.02%30.64M
8.46%29.19M
21.34%25.6M
63.99%97.36M
46.22%25.42M
48.63%23.93M
89.00%26.91M
Other operating expenses
-62.43%-1.75M
-90.44%-6.21M
-110.21%-2.9M
-50.14%-1.05M
-169.93%-1.19M
-44.70%-1.08M
67.95%-3.26M
-44.31%-1.38M
53.12%-698K
84.43%-439K
Operating profit
-90.68%-45.48M
-211.81%-144.89M
-298.48%-37.24M
-191.11%-42.23M
-1,197.93%-41.44M
-119.62%-23.85M
-49.20%129.59M
-91.25%18.76M
-117.93%-14.51M
114.23%3.77M
Net non-operating interest income expense
-5.92%7.39M
179.68%31.77M
12.54%7.84M
147.89%8.04M
656.54%8.04M
8,433.70%7.85M
14,465.38%11.36M
6.97M
3.24M
1.06M
Non-operating interest income
-5.92%7.39M
179.68%31.77M
12.54%7.84M
147.89%8.04M
656.54%8.04M
8,433.70%7.85M
14,465.38%11.36M
--6.97M
--3.24M
--1.06M
Other net income (expense)
26.93%2.09M
-47.57%4.08M
140.62%1.21M
-91.69%771K
-90.96%326K
177.97%1.65M
497.24%7.79M
-131.47%-2.99M
209.36%9.28M
5,910.00%3.61M
Other non- operating income (expenses)
26.93%2.09M
-47.57%4.08M
140.62%1.21M
-91.69%771K
-90.96%326K
177.97%1.65M
497.24%7.79M
-131.47%-2.99M
209.36%9.28M
5,910.00%3.61M
Income before tax
-150.85%-36M
-173.30%-109.03M
-223.93%-28.19M
-1,582.88%-33.42M
-491.66%-33.07M
-112.01%-14.35M
-42.01%148.74M
-89.85%22.75M
-102.74%-1.99M
131.91%8.44M
Income tax
84.65%2.21M
-93.07%3.61M
3.05%2.36M
60.33%-1.18M
-56.27%1.23M
-97.60%1.2M
24.18%52.08M
-94.15%2.29M
-207.43%-2.98M
2.82M
Net income
-145.75%-38.22M
-216.54%-112.64M
-249.37%-30.55M
-3,353.38%-32.24M
-709.67%-34.3M
-122.35%-15.55M
-54.95%96.65M
-88.94%20.45M
-98.58%991K
121.26%5.63M
Net income continuous Operations
-145.75%-38.22M
-216.54%-112.64M
-249.37%-30.55M
-3,353.38%-32.24M
-709.67%-34.3M
-122.35%-15.55M
-54.95%96.65M
-88.94%20.45M
-98.58%991K
121.26%5.63M
Minority interest income
Net income attributable to the parent company
-145.75%-38.22M
-216.54%-112.64M
-249.37%-30.55M
-3,353.38%-32.24M
-709.67%-34.3M
-122.35%-15.55M
-54.95%96.65M
-88.94%20.45M
-98.58%991K
121.26%5.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-145.75%-38.22M
-216.54%-112.64M
-249.37%-30.55M
-3,353.38%-32.24M
-709.67%-34.3M
-122.35%-15.55M
-54.95%96.65M
-88.94%20.45M
-98.58%991K
121.26%5.63M
Basic earnings per share
-143.18%-1.07
-215.81%-3.15
-246.55%-0.85
-3,100.00%-0.9
-700.00%-0.96
-122.45%-0.44
-55.41%2.72
-88.97%0.58
-98.48%0.03
121.33%0.16
Diluted earnings per share
-143.18%-1.07
-223.05%-3.15
-254.55%-0.85
-3,100.00%-0.9
-740.00%-0.96
-124.18%-0.44
-54.93%2.56
-88.75%0.55
-98.39%0.03
120.00%0.15
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0-95.29%12.6M000-91.74%12.6M-22.38%267.63M-77.59%53.91M-81.31%19.49M41.72M
Operating revenue --0-95.29%12.6M--0--0--0-91.74%12.6M-22.38%267.63M-77.59%53.91M-81.31%19.49M--41.72M
Cost of revenue
Gross profit
Operating expense 24.79%45.48M14.08%157.48M5.98%37.24M24.23%42.23M9.21%41.44M17.70%36.45M53.91%138.04M35.02%35.14M45.44%33.99M43.07%37.94M
Selling and administrative expenses 6.51%12.7M14.67%50.4M11.42%12.37M17.49%12.64M17.12%13.44M12.36%11.93M8.50%43.95M15.66%11.1M22.82%10.76M-24.04%11.47M
-General and administrative expense 6.51%12.7M14.67%50.4M11.42%12.37M17.49%12.64M17.12%13.44M12.36%11.93M8.50%43.95M15.66%11.1M22.82%10.76M-24.04%11.47M
Research and development costs 34.89%34.53M16.37%113.3M9.27%27.78M28.02%30.64M8.46%29.19M21.34%25.6M63.99%97.36M46.22%25.42M48.63%23.93M89.00%26.91M
Other operating expenses -62.43%-1.75M-90.44%-6.21M-110.21%-2.9M-50.14%-1.05M-169.93%-1.19M-44.70%-1.08M67.95%-3.26M-44.31%-1.38M53.12%-698K84.43%-439K
Operating profit -90.68%-45.48M-211.81%-144.89M-298.48%-37.24M-191.11%-42.23M-1,197.93%-41.44M-119.62%-23.85M-49.20%129.59M-91.25%18.76M-117.93%-14.51M114.23%3.77M
Net non-operating interest income expense -5.92%7.39M179.68%31.77M12.54%7.84M147.89%8.04M656.54%8.04M8,433.70%7.85M14,465.38%11.36M6.97M3.24M1.06M
Non-operating interest income -5.92%7.39M179.68%31.77M12.54%7.84M147.89%8.04M656.54%8.04M8,433.70%7.85M14,465.38%11.36M--6.97M--3.24M--1.06M
Other net income (expense) 26.93%2.09M-47.57%4.08M140.62%1.21M-91.69%771K-90.96%326K177.97%1.65M497.24%7.79M-131.47%-2.99M209.36%9.28M5,910.00%3.61M
Other non- operating income (expenses) 26.93%2.09M-47.57%4.08M140.62%1.21M-91.69%771K-90.96%326K177.97%1.65M497.24%7.79M-131.47%-2.99M209.36%9.28M5,910.00%3.61M
Income before tax -150.85%-36M-173.30%-109.03M-223.93%-28.19M-1,582.88%-33.42M-491.66%-33.07M-112.01%-14.35M-42.01%148.74M-89.85%22.75M-102.74%-1.99M131.91%8.44M
Income tax 84.65%2.21M-93.07%3.61M3.05%2.36M60.33%-1.18M-56.27%1.23M-97.60%1.2M24.18%52.08M-94.15%2.29M-207.43%-2.98M2.82M
Net income -145.75%-38.22M-216.54%-112.64M-249.37%-30.55M-3,353.38%-32.24M-709.67%-34.3M-122.35%-15.55M-54.95%96.65M-88.94%20.45M-98.58%991K121.26%5.63M
Net income continuous Operations -145.75%-38.22M-216.54%-112.64M-249.37%-30.55M-3,353.38%-32.24M-709.67%-34.3M-122.35%-15.55M-54.95%96.65M-88.94%20.45M-98.58%991K121.26%5.63M
Minority interest income
Net income attributable to the parent company -145.75%-38.22M-216.54%-112.64M-249.37%-30.55M-3,353.38%-32.24M-709.67%-34.3M-122.35%-15.55M-54.95%96.65M-88.94%20.45M-98.58%991K121.26%5.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -145.75%-38.22M-216.54%-112.64M-249.37%-30.55M-3,353.38%-32.24M-709.67%-34.3M-122.35%-15.55M-54.95%96.65M-88.94%20.45M-98.58%991K121.26%5.63M
Basic earnings per share -143.18%-1.07-215.81%-3.15-246.55%-0.85-3,100.00%-0.9-700.00%-0.96-122.45%-0.44-55.41%2.72-88.97%0.58-98.48%0.03121.33%0.16
Diluted earnings per share -143.18%-1.07-223.05%-3.15-254.55%-0.85-3,100.00%-0.9-740.00%-0.96-124.18%-0.44-54.93%2.56-88.75%0.55-98.39%0.03120.00%0.15
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg